These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32703436)

  • 1. Biophysical characterization of polydisperse liposomal adjuvant formulations.
    Singh P; Matyas GR; Anderson A; Beck Z
    Biochem Biophys Res Commun; 2020 Aug; 529(2):362-365. PubMed ID: 32703436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.
    Beck Z; Matyas GR; Jalah R; Rao M; Polonis VR; Alving CR
    Vaccine; 2015 Oct; 33(42):5578-5587. PubMed ID: 26372857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saturated phospholipids are required for nano- to micron-size transformation of cholesterol-containing liposomes upon QS21 addition.
    Singh P; Beck Z; Matyas GR; Alving CR
    J Liposome Res; 2019 Sep; 29(3):247-250. PubMed ID: 30350748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Immunogenicity and Protective Efficacy of a
    Ramakrishnan A; Schumack NM; Gariepy CL; Eggleston H; Nunez G; Espinoza N; Nieto M; Castillo R; Rojas J; McCoy AJ; Beck Z; Matyas GR; Alving CR; Guerry P; Poly F; Laird RM
    mSphere; 2019 May; 4(3):. PubMed ID: 31043512
    [No Abstract]   [Full Text] [Related]  

  • 5. QS21-Initiated Fusion of Liposomal Small Unilamellar Vesicles to Form ALFQ Results in Concentration of Most of the Monophosphoryl Lipid A, QS21, and Cholesterol in Giant Unilamellar Vesicles.
    Abucayon EG; Rao M; Matyas GR; Alving CR
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
    Beck Z; Torres OB; Matyas GR; Lanar DE; Alving CR
    J Control Release; 2018 Apr; 275():12-19. PubMed ID: 29432824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013.
    Genito CJ; Beck Z; Phares TW; Kalle F; Limbach KJ; Stefaniak ME; Patterson NB; Bergmann-Leitner ES; Waters NC; Matyas GR; Alving CR; Dutta S
    Vaccine; 2017 Jul; 35(31):3865-3874. PubMed ID: 28596090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Army Liposome Formulation (ALF) family of vaccine adjuvants.
    Alving CR; Peachman KK; Matyas GR; Rao M; Beck Z
    Expert Rev Vaccines; 2020 Mar; 19(3):279-292. PubMed ID: 32228108
    [No Abstract]   [Full Text] [Related]  

  • 9. Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21.
    Alving CR; Rao M; Matyas GR
    Front Immunol; 2023; 14():1102524. PubMed ID: 36761767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate.
    Beck Z; Matyas GR; Alving CR
    Biochim Biophys Acta; 2015 Mar; 1848(3):775-80. PubMed ID: 25511587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ).
    Cawlfield A; Genito CJ; Beck Z; Bergmann-Leitner ES; Bitzer AA; Soto K; Zou X; Hadiwidjojo SH; Gerbasi RV; Mullins AB; Noe A; Waters NC; Alving CR; Matyas GR; Dutta S
    Vaccine; 2019 Jun; 37(29):3793-3803. PubMed ID: 31151801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle size analyses of polydisperse liposome formulations with a novel multispectral advanced nanoparticle tracking technology.
    Singh P; Bodycomb J; Travers B; Tatarkiewicz K; Travers S; Matyas GR; Beck Z
    Int J Pharm; 2019 Jul; 566():680-686. PubMed ID: 31176851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines.
    Alving CR; Rao M; Steers NJ; Matyas GR; Mayorov AV
    Expert Rev Vaccines; 2012 Jun; 11(6):733-44. PubMed ID: 22873129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.
    Changsan N; Chan HK; Separovic F; Srichana T
    J Pharm Sci; 2009 Feb; 98(2):628-39. PubMed ID: 18484099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability.
    Mabrouk MT; Huang WC; Deng B; Li-Purcell N; Seffouh A; Ortega J; Ekin Atilla-Gokcumen G; Long CA; Miura K; Lovell JF
    Int J Pharm; 2020 Nov; 589():119843. PubMed ID: 32890653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome Formulations as Adjuvants for Vaccines.
    Rao M; Peachman KK; Alving CR
    Curr Top Microbiol Immunol; 2021; 433():1-28. PubMed ID: 33165871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Army liposome formulation containing QS-21 render human monocyte-derived macrophages less permissive to HIV-1 infection by upregulating ABOBEC3A.
    Jobe O; Kim J; Pinto DO; Villar Z; Hewitt T; Duncan EH; Anderson A; Gohain N; Gong H; Tucker C; Alving CR; Matyas GR; Bergmann-Leitner E; Rao M
    Sci Rep; 2022 May; 12(1):7570. PubMed ID: 35534646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal adjuvants for human vaccines.
    Alving CR; Beck Z; Matyas GR; Rao M
    Expert Opin Drug Deliv; 2016 Jun; 13(6):807-16. PubMed ID: 26866300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation.
    Alving CR; Rao M; Peachman KK; Asher L; Rao VB
    J Liposome Res; 2011 Dec; 21(4):279-85. PubMed ID: 21401373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.